Stock APLI APPILI THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Appili Therapeutics Inc.

Equities

APLI

CA03783R1073

Market Closed - Toronto S.E.
Other stock markets
 18:07:49 10/05/2024 BST 		5-day change 1st Jan Change
0.035 CAD 0.00% Intraday chart for Appili Therapeutics Inc. 0.00% 0.00%
04-26 Appili Therapeutics Inc. announced that it has received CAD 0.3 million in funding CI
04-02 Appili Therapeutics To be Acquired by Aditxt, Inc. MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Appili Therapeutics Inc. Appoints Prakash Gowd to its Board of Directors
CI
Appili Therapeutics Q2 Net Loss and Comprehensive Loss Narrows Vs a Year Ago
MT
Appili Therapeutics Inc. Announces Demise of Rochelle Stenzler, as the Director of the Company
CI
Appili Therapeutics Inc. Appoints Gary Nabors as Chief Development Officer
CI
Appili Therapeutics Appoints Dr. Carl Gelhaus and Arthur Baran to Support ATI-1701 Biodefense Vaccine Program
MT
Appili Therapeutics Inc. Announces Executive Appointments
CI
Appili Therapeutics Inc. Announces Management Changes
CI
Appili Therapeutics Inc. Promotes Don Cilla to the Position of Chief Executive Officer
CI
Appili Details "Positive" One Year Challenge Results from Preclinical Study Evaluating Biodefense Vaccine Candidate, Change to Board of Directors
MT
Appili Therapeutics Inc. Announces Resignation of Josef Vejvoda from the Board of Directors
CI
Appili Therapeutics Inc. Appoints Josef Vejvoda to Its Board of Directors
CI
Appili Therapeutics Inc. Appoints Rochelle Stenzler as Board of Directors
CI
Appili Therapeutics Inc. Announces Appointment of Don Cilla as Chief Development Officer, Effective November 1, 2020
CI
Appili Therapeutics Inc. Appoints Yoav Golan, MD, to Serve as First Chief Medical Officer
CI
Appili Therapeutics Inc. Announces Board Changes
CI
Appili Therapeutics Inc. Announces Executive Changes
CI
Appili Therapeutics Inc. Appoints Theresa Matkovits to its Board of Directors
CI
Appili Therapeutics Inc. Appoints Armand Balboni as First Chief Scientific Officer
CI
Appili Therapeutics Appoints Seasoned Biotech Executive Ian C. Mortimer to its Board
CI
Appili Therapeutics Inc. Names Sean McBride as Vice President, Business Development
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APLI Stock
  4. News Appili Therapeutics Inc.
  5. Insiders